Overview of factors contributing to the pathophysiology of progressive renal disease

Kidney International

Volumn 74, Issue 7, 2008, Pages 860-866

  Schlondorff, Detlef O ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerulosclerosis; Hypoxia; Interstitial fibrosis; Ischemia; Matrix remodelling; Progression of renal disease

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; TOLL LIKE RECEPTOR;

DISEASE COURSE; GLOMERULOSCLEROSIS; HUMAN; HYPOXIA; INFLAMMATORY INFILTRATE; KIDNEY BLOOD VESSEL; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REPAIR; VALIDATION STUDY;

EID: 51849083714     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.351     Document Type: Article

References (23)

1. Segerer S, Kretzler M, Strutz F et al. Mechanisms of tissue injury and repair in renal diseases. In: Schrier R (ed). Diseases of the Kidney and Urinary Tract. Lippincott, Philadelphia, 2007.
2. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147.
3. Ballermann BJ, Stan RV. Resolved:capillary endothelium is a major contributor to the glomerular filtration barrier. J Am Soc Nephrol 2007; 18: 2432-2438.
4. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human transplants. Nat Med 2006; 12: 230-234.
5. John R, Nelson PJ. Dendritic cells in the Kidney. J Am Soc Nephrol 2007; 18: 2628-2635.
6. Hostetter T. Hyperfiltration and glomerulosclerosis seminars. Nephrology 2003; 23: 194-199.
7. Baylis C, Brenner B. The physiological determinants of ultrafiltration. Rev Physiol Biochem Pharmocol 1978; 80: 1-46.
8. 2. Microvasc Res 1972; 4: 247-257.
9. Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev 2006; 86: 1133-1149.
10. Anders HJ, Schlondorff D. Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 2007; 16: 177-183.
11. Anders HJ, Banas B, Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867.
12. Ferguson MWJ, O'Kane S. Scar-free healing:from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc London B 2004; 359: 839-850.
13. Zandi-Nejad K, Eddy AA, Glassock RJ et al. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int 2004; 65(Suppl 93): S76-S89.
14. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
15. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
16. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
17. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859.
18. Lang A, Benke D, Eitner F et al. Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J Am Soc Nephrol 2005; 16: 383-391.
19. Seki E, De Minicis S, Osterreicher CH et al. TLR4 enhances TGF-b signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-1332.
20. Anders HJ, Vielhauer V, Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 2003; 63: 401-415.
21. Segerer S, Schlöndorff D. Role of chemokines for the localization of leukocytes subsets in the kidney. Semin Nephrol 2007; 7: 260-274.
22. Wada T, Sakai N, Matsushima K et al. Fibrocytes:a new insight into kidney fibrosis. Kidney Int 2007; 72: 268-273.
23. Remuzzi A, Gagliardini E, Sangalli F et al. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 2006; 69: 1124-1130.